Compare · SHMD vs TMO
SHMD vs TMO
Side-by-side comparison of SCHMID Group N.V. (SHMD) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- SHMD operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 601.9x SHMD ($291.9M).
- Over the past year, SHMD is up 97.9% and TMO is up 15.8% - SHMD leads by 82.1 points.
- Both names hit the wire about 17 times in the past 4 weeks.
- TMO has more recent analyst coverage (25 ratings vs 0 for SHMD).
- Company
- SCHMID Group N.V.
- Thermo Fisher Scientific Inc
- Price
- $5.18+2.47%
- $473.45+0.16%
- Market cap
- $291.9M
- $175.70B
- 1M return
- -8.88%
- -0.26%
- 1Y return
- +97.90%
- +15.81%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 17
- 17
- Recent ratings
- 0
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest SHMD
- Amendment: COO of Gebr. Schmid GmbH Rauch Helmut covered exercise/tax liability with 27,425 units of Ordinary Shares, decreasing direct ownership by 63% to 12,766 units (SEC Form 4)
- Amendment: Chief Executive Officer Schmid Christian Mathias covered exercise/tax liability with 18,975 units of Ordinary Shares, decreasing direct ownership by 51% to 18,175 units (SEC Form 4)
- Amendment: Director Schmid Anette covered exercise/tax liability with 11,136 units of Ordinary Shares, decreasing direct ownership by 46% to 13,111 units (SEC Form 4)
- CFO Schmid Group N.V. Schuetz Arthur Josef Hermann was granted 24,000 units of Ordinary Shares (SEC Form 4)
- Director Yoon Boo Keun increased direct ownership by 51% to 26,397 units (SEC Form 4)
- SEC Form 4 filed by Director Streyl Annedore
- COO of Gebr. Schmid GmbH Rauch Helmut was granted 24,000 units of Ordinary Shares (SEC Form 4)
- CEO Schmid Christian Mathias acquired $9,275,949 worth of Ordinary Shares (1,265,322 units at $7.33) (SEC Form 4)
- Director Schmid Anette acquired $16,058,989 worth of Ordinary Shares (2,190,589 units at $7.33) and returned $16,058,989 worth of Ordinary Shares to the company (2,190,589 units at $7.33) (SEC Form 4)
- SEC Form S-8 filed by SCHMID Group N.V.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)